Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol

Author:

Khan YasmineORCID,Verhaeghe Nick,De Pauw RobbyORCID,Devleesschauwer Brecht,Gadeyne Sylvie,Gorasso Vanessa,Lievens Yolande,Speybroek Niko,Vandamme NancyORCID,Vandemaele Miet,Van den Borre Laura,Vandepitte Sophie,Vanthomme Katrien,Verdoodt Freija,De Smedt Delphine

Abstract

IntroductionCancer causes a substantial burden to our society, both from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely treatment are essential. The recent COVID-19 crisis has disrupted the care trajectory of cancer patients, which may affect their prognosis in a potentially negative way. The purpose of this paper is to present a flexible decision-analytic Markov model methodology allowing the evaluation of the impact of delayed cancer care caused by the COVID-19 pandemic in Belgium which can be used by researchers to respond to diverse research questions in a variety of disruptive events, contexts and settings.MethodsA decision-analytic Markov model was developed for 4 selected cancer types (i.e. breast, colorectal, lung, and head and neck), comparing the estimated costs and quality-adjusted life year losses between the pre-COVID-19 situation and the COVID-19 pandemic in Belgium. Input parameters were derived from published studies (transition probabilities, utilities and indirect costs) and administrative databases (epidemiological data and direct medical costs). One-way and probabilistic sensitivity analyses are proposed to consider uncertainty in the input parameters and to assess the robustness of the model’s results. Scenario analyses are suggested to evaluate methodological and structural assumptions.DiscussionThe results that such decision-analytic Markov model can provide are of interest to decision makers because they help them to effectively allocate resources to improve the health outcomes of cancer patients and to reduce the costs of care for both patients and healthcare systems. Our study provides insights into methodological aspects of conducting a health economic evaluation of cancer care and COVID-19 including insights on cancer type selection, the elaboration of a Markov model, data inputs and analysis.

Funder

Belgian Federal Science Policy Office

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. ECIS. Estimates of cancer incidence and mortality in 2020, for all cancer sites. 2022 [Cited 2022 April 10]; Available from: https://ecis.jrc.ec.europa.eu/explorer.php?$0-0$1-AEE$2-All$4-1,2$3-All$6-0,85$5-2020,2020$7-7$CEstByCancer$X0_8-3$CEstRelativeCanc$X1_8-3$X1_9-AE27$CEstBySexByCancer$X2_8-3$X2_-1-1

2. Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease (GBD). 2022 [Cited 2022 April 5]; Available from: https://vizhub.healthdata.org/gbd-compare/

3. The cost of cancer in Europe 2018;T Hofmarcher;Eur J Cancer,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3